Works matching IS 09255710 AND DT 2020 AND VI 112 AND IP 1


Results: 19
    1
    3
    4

    Comparison of starting doses of anagrelide as a first-line therapy in patients with cytoreductive therapy-naïve essential thrombocythemia: difference between starting at 0.5 and 1.0 mg/day.

    Published in:
    2020
    By:
    • Hashimoto, Yoshinori;
    • Ito, Tomoki;
    • Tanaka, Yasuhiro;
    • Nakaya, Aya;
    • Fujita, Shinya;
    • Satake, Atsushi;
    • Nakanishi, Takahisa;
    • Konishi, Akiko;
    • Hotta, Masaaki;
    • Yoshimura, Hideaki;
    • Ishii, Kazuyoshi;
    • Hashimoto, Akiko;
    • Kondo, Toshinori;
    • Omura, Hiromi;
    • Shinzato, Isaku;
    • Tanaka, Takayuki;
    • Nomura, Shosaku
    Publication type:
    journal article
    5
    6
    7
    9
    10
    11
    12
    13
    14

    Computed tomography-defined sarcopenia: prognostic predictor of nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study.

    Published in:
    2020
    By:
    • Ando, Taiki;
    • Fujisawa, Shin;
    • Teshigawara, Haruka;
    • Matsumura, Ayako;
    • Sakuma, Takayuki;
    • Suzuki, Taisei;
    • Teranaka, Hiroshi;
    • Ogusa, Eriko;
    • Ishii, Yoshimi;
    • Miyashita, Kazuho;
    • Takahashi, Hiroyuki;
    • Nakajima, Yuki;
    • Miyazaki, Takuya;
    • Hagihara, Maki;
    • Matsumoto, Kenji;
    • Yamazaki, Etsuko;
    • Nakajima, Hideaki
    Publication type:
    journal article
    15
    16
    17
    18
    19